Skip to main content
. 2020 Oct 15;7:191–199. doi: 10.2147/JHC.S274349

Table 2.

Univariate Analysis for Risk Factors of OS After TACE Treatment

ΔPLT≥20 (×109/L) ΔPLT≤-20 (×109/L)
Statistics HR (95% CI) Statistics HR (95% CI)
Gender
 Male 318 (91.38%) 1 396 (92.74%) 1
 Female 30 (8.62%) 1.35 (0.83, 2.20) 31 (7.26%) 1.17 (0.72, 1.89)
Age (yrs)
 <55 148 (42.53%) 1 201 (47.07%) 1
 ≥55 200 (57.47%) 0.98 (0.74, 1.30) 226 (52.93%) 0.88 (0.69, 1.14)
PS score
 0 287 (82.47%) 1 351 (82.20%) 1
 1 61 (17.53%) 3.17 (2.24, 4.48) 76 (17.80%) 2.16 (1.58, 2.96)
Diameter of main tumour (cm)
 <5 190 (54.60%) 1 231 (54.10%) 1
 ≥5 158 (45.40%) 2.76 (2.08, 3.68) 196 (45.90%) 2.87 (2.22, 3.71)
AFP (ng/mL)
 <25 140 (40.23%) 1 145 (33.96%) 1
 ≥25 196 (56.32%) 2.58 (1.90, 3.50) 232 (54.33%) 2.29 (1.72, 3.06)
 NA 12 (3.45%) 1.65 (0.71, 3.81) 50 (11.71%) 1.20 (0.76, 1.88)
Hgb (g/L)
 <120 112 (32.18%) 1 96 (27.83%) 1
 ≥120 236 (67.82%) 0.65 (0.48, 0.86) 249 (72.17%) 0.79 (0.58, 1.08)
CRP (mg/L)
 <10 172 (49.43%) 1 196 (45.90%) 1
 ≥10 136 (39.08%) 1.97 (1.46, 2.65) 129 (30.21%) 1.77 (1.32, 2.35)
 NA 40 (11.49%) 1.34 (0.84, 2.12) 102 (23.89%) 1.21 (0.87, 1.67)
WBC (109/L)
 <11 316 (91.33%) 1 316 (92.13%) 1
 ≥11 30 (8.67%) 1.64 (1.03, 2.60) 27 (7.87%) 1.18 (0.72, 1.94)
No. of intrahepatic lesions
 0 96 (27.59%) 1 117 (27.40%) 1
 ≤3 86 (24.71%) 2.02 (1.33, 3.05) 115 (26.93%) 1.58 (1.09, 2.28)
 >3 166 (47.70%) 3.06 (2.11, 4.44) 195 (45.67%) 3.02 (2.18, 4.18)
Location of Lesions
 None 96 (27.59%) 1 117 (27.40%) 1
 Left/Right 98 (28.16%) 2.01 (1.34, 3.02) 121 (28.34%) 1.54 (1.06, 2.23)
 Both 154 (44.25%) 3.17 (2.18, 4.62) 188 (44.26%) 3.07 (2.21, 4.25)
Child-Pugh class
 A 164 (47.13%) 1 174 (40.75%) 1
 B 32 (9.20%) 1.50 (0.92, 2.44) 45 (10.54%) 1.58 (1.06, 2.35)
 NA 152 (43.68%) 0.99 (0.74, 1.33) 208 (48.71%) 0.92 (0.70, 1.21)

Note: Numbers that do not add up to 348 (ΔPLT ≥20 vs ΔPLT±20) or 427 (ΔPLT≤-20 vs ΔPLT±20) are attributable to missing data.